Exact Mass: 610.2539704000001
Exact Mass Matches: 610.2539704000001
Found 118 metabolites which its exact mass value is equals to given mass value 610.2539704000001,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Candesartan cilexetil
C33H34N6O6 (610.2539704000001)
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Candesartan Cilexetil (TCV-116) is an angiotensin II receptor inhibitor. Candesartan Cilexetil ameliorates the pulmonary fibrosis and has antiviral and skin wound healing effect. Candesartan Cilexetil can be used for the research of high blood pressure[1][2][3][4][5][6].
Carboxypeptidase B
Hydrolase is a member of the class of compounds known as oligopeptides. Oligopeptides are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. Hydrolase is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Hydrolase can be found in cocoa bean, which makes hydrolase a potential biomarker for the consumption of this food product. In biochemistry, a hydrolase is an enzyme that catalyzes the hydrolysis of a chemical bond. For example, an enzyme that catalyzes the following reaction is a hydrolase: A–B + H2O → A–OH + B–H .
1beta,7beta-dihydroxy-4beta,20-epoxy-2alpha,5alpha,9alpha,10beta,13alpha-pentaacetoxy-tax-11-ene|1beta,7beta-dihydroxy-4beta,20-epoxy-2alpha,5alpha,9alpha,10beta,13alpha-pentaacetoxytax-11-ene
1??,9??-Dihydroxy-4??,20-epoxy-2??,5??,7??,10??,13??-penta-acetoxytax-11-ene
Phe Met Gln Trp
C30H38N6O6S (610.2573408000001)
Phe Met Trp Gln
C30H38N6O6S (610.2573408000001)
Phe Gln Met Trp
C30H38N6O6S (610.2573408000001)
Phe Gln Trp Met
C30H38N6O6S (610.2573408000001)
Phe Trp Met Gln
C30H38N6O6S (610.2573408000001)
Phe Trp Gln Met
C30H38N6O6S (610.2573408000001)
Gly Trp Trp Tyr
C33H34N6O6 (610.2539704000001)
Gly Trp Tyr Trp
C33H34N6O6 (610.2539704000001)
Gly Tyr Trp Trp
C33H34N6O6 (610.2539704000001)
Met Phe Gln Trp
C30H38N6O6S (610.2573408000001)
Met Phe Trp Gln
C30H38N6O6S (610.2573408000001)
Met Gln Phe Trp
C30H38N6O6S (610.2573408000001)
Met Gln Trp Phe
C30H38N6O6S (610.2573408000001)
Met Trp Phe Gln
C30H38N6O6S (610.2573408000001)
Met Trp Gln Phe
C30H38N6O6S (610.2573408000001)
Gln Phe Met Trp
C30H38N6O6S (610.2573408000001)
Gln Phe Trp Met
C30H38N6O6S (610.2573408000001)
Gln Met Phe Trp
C30H38N6O6S (610.2573408000001)
Gln Met Trp Phe
C30H38N6O6S (610.2573408000001)
Gln Trp Phe Met
C30H38N6O6S (610.2573408000001)
Gln Trp Met Phe
C30H38N6O6S (610.2573408000001)
Trp Phe Met Gln
C30H38N6O6S (610.2573408000001)
Trp Phe Gln Met
C30H38N6O6S (610.2573408000001)
Trp Gly Trp Tyr
C33H34N6O6 (610.2539704000001)
Trp Gly Tyr Trp
C33H34N6O6 (610.2539704000001)
Trp Met Phe Gln
C30H38N6O6S (610.2573408000001)
Trp Met Gln Phe
C30H38N6O6S (610.2573408000001)
Trp Gln Phe Met
C30H38N6O6S (610.2573408000001)
Trp Gln Met Phe
C30H38N6O6S (610.2573408000001)
Trp Trp Gly Tyr
C33H34N6O6 (610.2539704000001)
Trp Trp Tyr Gly
C33H34N6O6 (610.2539704000001)
Trp Tyr Gly Trp
C33H34N6O6 (610.2539704000001)
Trp Tyr Trp Gly
C33H34N6O6 (610.2539704000001)
Tyr Gly Trp Trp
C33H34N6O6 (610.2539704000001)
Tyr Trp Gly Trp
C33H34N6O6 (610.2539704000001)
Tyr Trp Trp Gly
C33H34N6O6 (610.2539704000001)
1,3,3-trimethyl-2-(2-(2-phenyl-3-(2-(1,3,3-trimethyl-1h-2(3h)- indolidene)ethylidene)-1-cyclopentenyl)ethenyl)-3h-indolium perchlorate
2-Desethoxy-2-hydroxy-1H-1-Ethyl Candesartan Cilexetil
C33H34N6O6 (610.2539704000001)
2-Desethoxy-2-hydroxy-2H-2-ethyl Candesartan Cilexetil
C33H34N6O6 (610.2539704000001)
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(4-methylphenyl)sulfonylamino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
3-methoxy-N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
Candesartan cilexetil
C33H34N6O6 (610.2539704000001)
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Candesartan Cilexetil (TCV-116) is an angiotensin II receptor inhibitor. Candesartan Cilexetil ameliorates the pulmonary fibrosis and has antiviral and skin wound healing effect. Candesartan Cilexetil can be used for the research of high blood pressure[1][2][3][4][5][6].
N-acetyl-beta-D-glucosaminyl-1,6-(N-acetyl-beta-D-glucosaminyl-1,3)-N-acetyl-D-galactosaminyl group
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-oxo-4-(tritylamino)butanoic acid
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-oxo-4-(tritylamino)butanoic acid is an asparagine derivative[1].
(1's,2r,2's,3'r,5's,7's,8's,9'r,10'r,13's)-2',7',9',10'-tetrakis(acetyloxy)-1',13'-dihydroxy-8',12',15',15'-tetramethylspiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-5'-yl acetate
(1's,2s,2's,3'r,5's,7's,8's,9'r,10'r,13's)-2',5',9',10'-tetrakis(acetyloxy)-1',13'-dihydroxy-8',12',15',15'-tetramethylspiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-7'-yl acetate
(1r,2r,3r,4s,5r,7r,8r,9s,10s,11s,12z,14r,17s)-2,7,10-tris(acetyloxy)-5,9-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-11-yl butanoate
(1's,2s,2's,3'r,5's,7's,8's,9'r,10'r,13's)-2',5',9',10'-tetrakis(acetyloxy)-1',7'-dihydroxy-8',12',15',15'-tetramethylspiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-13'-yl acetate
2,7,9-tris(acetyloxy)-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-11-yl butanoate
(1s,2s,3r,4s,7r,9s,10s,11r,12r,15s)-2,11,12,15-tetrakis(acetyloxy)-1,4-dihydroxy-10,14,17,17-tetramethyl-6-oxatetracyclo[11.3.1.0³,¹⁰.0⁴,⁷]heptadec-13-en-9-yl acetate
2,5,9,11-tetrakis(acetyloxy)-8-hydroxy-3-(2-hydroxypropan-2-yl)-6,10-dimethyl-14-oxatetracyclo[8.6.0.0³,⁷.0¹³,¹⁶]hexadec-6-en-16-yl acetate
1beta,7beta-dihydroxy-4beta,20-epoxy-2alpha,5alpha,9alpha,10beta,13alpha-pentaacetoxytax-11-ene
{"Ingredient_id": "HBIN002376","Ingredient_name": "1beta,7beta-dihydroxy-4beta,20-epoxy-2alpha,5alpha,9alpha,10beta,13alpha-pentaacetoxytax-11-ene","Alias": "1\u03b2,7\u03b2-dihydroxy-4\u03b2,20-epoxy-2\u03b1,5\u03b1,9\u03b1,10\u03b2,13\u03b1-pentaacetoxytax-11-ene","Ingredient_formula": "C30H42O13","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C4(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)CO4)OC(=O)C)O)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25904;5880","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1beta,9alpha-dihydroxy-4beta,20-epoxy-2alpha,5alpha,7beta,10beta,13alpha-penta-acetoxytax-11-ene
{"Ingredient_id": "HBIN002377","Ingredient_name": "1beta,9alpha-dihydroxy-4beta,20-epoxy-2alpha,5alpha,7beta,10beta,13alpha-penta-acetoxytax-11-ene","Alias": "1\u03b2,9\u03b1-dihydroxy-4\u03b2,20-epoxy-2\u03b1,5\u03b1,7\u03b2,10\u03b2,13\u03b1-penta-acetoxytax-11-ene","Ingredient_formula": "C30H42O13","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C4(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)CO4)OC(=O)C)OC(=O)C)C)O)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25903;5881","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1beta-hydroxy-7beta-deacetyoxy-1alpha-hydroxybaccatin i
{"Ingredient_id": "HBIN002404","Ingredient_name": "1beta-hydroxy-7beta-deacetyoxy-1alpha-hydroxybaccatin i","Alias": "NA","Ingredient_formula": "C30H42O13","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C4(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)CO4)OC(=O)C)O)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31175","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1β-hydroxy-7β-deacetyoxy-7α-hydroxybaccatini
{"Ingredient_id": "HBIN002405","Ingredient_name": "1\u03b2-hydroxy-7\u03b2-deacetyoxy-7\u03b1-hydroxybaccatini","Alias": "NA","Ingredient_formula": "C30H42O13","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9964","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-deacetylbaccatin iv
{"Ingredient_id": "HBIN010309","Ingredient_name": "4-deacetylbaccatin iv","Alias": "NA","Ingredient_formula": "C30H42O13","Ingredient_Smile": "CC1=C2C(C(C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)(CO4)O)OC(=O)C)C)OC(=O)C)OC(=O)C","Ingredient_weight": "610.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4723","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101670647","DrugBank_id": "NA"}